Upregulation of PD–L1 allows tumors to escape from the host immune surveillance; in fact, analyzing 196 tumor specimens of renal cell carcinoma, high PD–L1 expression was associated with increased tumor aggressiveness and a 4.5–fold increased risk of death. The gene discussed is CD274; the disease is renal cell carcinoma.